RPL35AP37

Across TCGA pan-cancer cohorts, RPL35AP37 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RPL35AP37 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPL35AP37 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL35AP37 expression acts as an unfavorable survival marker, although some lineages such as CESC and LIHC show a favorable association.

KIRC, ACC, and UCS are the cancer types where RPL35AP37 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.444	0.638	.001	117	view →
ACC	OS	Tertile	III,IV	0.145	0.766	<.001	90	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	72	view →
OV	OS	Quartile	All	0.243	0.348	.003	44	view →
DLBC	OS	Tertile	III,IV	0.172	1.000	.014	24	view →
KICH	DFS	Tertile	II,III,IV	0.287	0.807	.011	18	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	18	view →
LUAD	OS	Tertile	All	0.623	0.807	.009	18	view →
SKCM	DFS	Quartile	IV	0.016	0.546	.025	15	view →
CESC	OS	Tertile	All	0.955	0.782	.045	12	view →
UVM	OS	Tertile	III,IV	0.220	0.872	.025	9	view →
THCA	OS	Tertile	All	0.943	0.983	.024	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RPL35AP37–KIRC (DFS)

Open the KIRC breakdown →